Lenacapavir could be a gamechanger in the fight against infection. But US funding cuts have thrown the rollout of the ...

Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...

In the face of a fear of loss of funds for ending the HIV/AIDS epidemic, activists in New Jersey walked to raise money.

Exclusive: World Health Organisation says shortage of most commonly used Aids drug caused by withdrawal of US foreign aid ...

His lab at South Africa’s University of the Witwatersrand (Wits) had already spent thousands of dollars in US funding on ...

Communities in the Kenya’s and Uganda’s shores of Lake Victoria, Copperbelt Province in Zambia, Eastern Cape Province in ...

On April 22, the CDC allegedly informed Emory University in Atlanta that its large HIV self-testing program was being ...

In a first-ever milestone, Africa’s initial HIV cure trial has yielded historic findings: 20% of patients have remained off ...

NEW YORK (Reuters) -Gilead Sciences has reached a $202 million settlement to resolve a civil fraud lawsuit accusing the ...